172 related articles for article (PubMed ID: 6169265)
1. The influence of a new corticosteroid, budesonide, on anaphylactic bronchoconstriction and SRS-A release in the guinea pig.
Forsberg K; Sörenby L
Agents Actions; 1981 Jul; 11(4):391-5. PubMed ID: 6169265
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of the glucocorticoid, budesonide, on lung anaphylaxis in actively sensitized guinea-pigs: inhibition of IgE-but not of IgG-mediated anaphylaxis.
Andersson P; Brattsand R
Br J Pharmacol; 1982 May; 76(1):139-47. PubMed ID: 7082901
[TBL] [Abstract][Full Text] [Related]
3. Non-immunological release of slow-reacting substance from guinea-pig lungs.
Piper PJ; Seale JP
Br J Pharmacol; 1979 Sep; 67(1):67-72. PubMed ID: 91403
[TBL] [Abstract][Full Text] [Related]
4. KC-404: a potential anti-allergic agent with antagonistic action against slow reacting substance of anaphylaxis.
Nishino K; Ohkubo H; Ohashi M; Hara S; Kito J; Irikura T
Jpn J Pharmacol; 1983 Apr; 33(2):267-78. PubMed ID: 6193303
[TBL] [Abstract][Full Text] [Related]
5. Anaphylaxis in chopped guinea pig lung. II. Enhancement of the anaphylactic release of histamine and slow reacting substance by certain dibasic aliphatic acids and inhibition by monobasic fatty acids.
AUSTEN KF; BROCKLEHURST WE
J Exp Med; 1961 Mar; 113(3):541-57. PubMed ID: 13685195
[TBL] [Abstract][Full Text] [Related]
6. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.
Engineer DM; Niederhauser U; Piper PJ; Sirois P
Br J Pharmacol; 1978 Jan; 62(1):61-6. PubMed ID: 74266
[TBL] [Abstract][Full Text] [Related]
7. Effect of butyl 3-(1H-tetrazol-5-Yl) oxanilate (MTB) on immunological or non-immunological histamine and SRS(-A) release from guinea-pig, monkey and human lung tissue.
Hashimoto T; Kohno SW; Ohata K; Yanagihara Y; Shida T
Jpn J Pharmacol; 1987 Aug; 44(4):447-53. PubMed ID: 2446036
[TBL] [Abstract][Full Text] [Related]
8. Release of prostaglandins, a prostaglandin metabolite, slow-reacting substance and histamine from anaphylactic lungs, and its modification by catecholamines.
Liebig R; Bernauer W; Peskar BA
Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(3):279-93. PubMed ID: 4139670
[No Abstract] [Full Text] [Related]
9. Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis.
Ohashi M; Uno T; Nishino K
Int Arch Allergy Immunol; 1993; 101(3):288-96. PubMed ID: 8324390
[TBL] [Abstract][Full Text] [Related]
10. The effect of indomethacin on anaphylactic contraction and histamine release in guinea-pig lung parenchymal strips.
Creese BR; Temple DM
Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):265-76. PubMed ID: 2428325
[TBL] [Abstract][Full Text] [Related]
11. Effect of glucocorticosteroid treatment on ovalbumin-induced IgE-mediated immediate and late allergic response in guinea pig.
Andersson P; Brange C; von Kogerer B; Sonmark B; Stahre G
Int Arch Allergy Appl Immunol; 1988; 87(1):32-9. PubMed ID: 2459068
[TBL] [Abstract][Full Text] [Related]
12. [Effect of prostaglandins on anaphylactic release of histamine and slow reacting substance of anaphylaxis (SR -A) from guinea pig lung tissues (author's transl)].
Kitamura S; Ishihara Y; Izumi T; Sugiyama Y; Hayashi R; Hsu LH
Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Jul; 18(7):447-52. PubMed ID: 6162989
[No Abstract] [Full Text] [Related]
13. SRS-A mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo.
Ritchie DM; Sierchio JN; Capetola RJ; Rosenthale ME
Agents Actions; 1981 Jul; 11(4):396-401. PubMed ID: 7282491
[TBL] [Abstract][Full Text] [Related]
14. Antianaphylactic agents. 1. 2-(Acylamino)oxazoles.
Ross WJ; Harrison RG; Jolley MR; Neville MC; Todd A; Verge JP; Dawson W; Sweatman WJ
J Med Chem; 1979 Apr; 22(4):412-7. PubMed ID: 430478
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of anaphylactic mediator release from guinea-pig perfused lungs by fatty acid hydroperoxides.
Adcock JJ; Garland LG; Moncada S; Salmon JA
Prostaglandins; 1978 Aug; 16(2):163-77. PubMed ID: 81494
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhibitors of anaphylactic mediators in two models of bronchial anaphylaxis in anaesthetized guinea-pigs.
Andersson P
Br J Pharmacol; 1982 Oct; 77(2):301-7. PubMed ID: 6814558
[TBL] [Abstract][Full Text] [Related]
17. Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat.
Stechschulte DJ; Austen KF; Bloch KJ
J Exp Med; 1967 Jan; 125(1):127-47. PubMed ID: 4163357
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of isamoxole [2-methyl-n-butyl-n(4-methyloxazol-2-yl) propanamide] LRCL 3950, a new anti-allergic compound.
Dawson W; Sweatman WJ
Br J Pharmacol; 1980; 71(2):387-98. PubMed ID: 6781575
[TBL] [Abstract][Full Text] [Related]
19. Use of steroidal antiinflammatory drug provides further evidence for a potential role of PAF-acether in bronchial anaphylaxis.
Chignard M; Le Còuedic JP; Andersson P; Brange C
Int Arch Allergy Appl Immunol; 1986; 81(2):184-5. PubMed ID: 3759260
[TBL] [Abstract][Full Text] [Related]
20. Effect of clenbuterol, a new beta 2 selective adrenoceptor stimulant, on the release of histamine and SRS-A from passively sensitized guinea-pig chopped lungs.
Yamazaki N; Hosoki R; Takayanagi I
Gen Pharmacol; 1984; 15(4):345-8. PubMed ID: 6208080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
